{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:16:49Z","timestamp":1788779809735,"version":"build-2803163510"},"reference-count":42,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T00:00:00Z","timestamp":1544745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>Malignant pleural mesothelioma (<jats:styled-content style=\"fixed-case\">MPM<\/jats:styled-content>), a highly refractory tumor, is currently incurable due to the lack of an early diagnosis method and medication, both of which are urgently needed to improve the survival and\/or quality of life of patients. <jats:italic><jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2<\/jats:italic> is a tumor suppressor gene and is frequently mutated in <jats:styled-content style=\"fixed-case\">MPM<\/jats:styled-content>. Using a <jats:styled-content style=\"fixed-case\">CRISPR<\/jats:styled-content>\/Cas9 system, we generated an <jats:italic><jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2\u2010<\/jats:italic>knockout human mesothelial cell line, MeT\u20105A (<jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2\u2010<jats:styled-content style=\"fixed-case\">KO<\/jats:styled-content>). In <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2\u2010<jats:styled-content style=\"fixed-case\">KO<\/jats:styled-content> cell clones, cell growth, clonogenic activity, migration activity, and invasion activity significantly increased compared with those in <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2\u2010<jats:styled-content style=\"fixed-case\">WT<\/jats:styled-content> cell clones. Complementary <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> microarray analysis clearly revealed the differences in global gene expression profile between <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2\u2010<jats:styled-content style=\"fixed-case\">WT<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2\u2010<jats:styled-content style=\"fixed-case\">KO<\/jats:styled-content> cell clones. Quantitative <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content> analysis and western blot analysis showed that the upregulation of fibroblast growth factor receptor 2 (<jats:styled-content style=\"fixed-case\">FGFR<\/jats:styled-content>2) was concomitant with the increases in phosphorylation levels of <jats:styled-content style=\"fixed-case\">JNK<\/jats:styled-content>, c\u2010Jun, and retinoblastoma (Rb) in <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2\u2010<jats:styled-content style=\"fixed-case\">KO<\/jats:styled-content> cell clones. These increases were all abrogated by the exogenous expression of <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2 in the <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2\u2010<jats:styled-content style=\"fixed-case\">KO<\/jats:styled-content> clone. In addition, the disruption of <jats:italic><jats:styled-content style=\"fixed-case\">FGFR<\/jats:styled-content>2<\/jats:italic> in the <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2\u2010<jats:styled-content style=\"fixed-case\">KO<\/jats:styled-content> cell clone suppressed cell proliferation as well as the phosphorylation levels of <jats:styled-content style=\"fixed-case\">JNK<\/jats:styled-content>, c\u2010Jun, and Rb. Notably, <jats:styled-content style=\"fixed-case\">FGFR<\/jats:styled-content>2 was found to be highly expressed in <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2\u2010negative human mesothelioma tissues (11\/12 cases, 91.7%) but less expressed in <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2\u2010positive tissues. Collectively, these findings suggest that <jats:italic><jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2<\/jats:italic> deficiency might play a role in the tumorigenesis of human mesothelium through mediating <jats:styled-content style=\"fixed-case\">FGFR<\/jats:styled-content>2 expression; <jats:styled-content style=\"fixed-case\">FGFR<\/jats:styled-content>2 would be a candidate molecule to develop therapeutic and diagnostic strategies for targeting <jats:styled-content style=\"fixed-case\">MPM<\/jats:styled-content> with <jats:italic><jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>2<\/jats:italic> loss.<\/jats:p>","DOI":"10.1111\/cas.13871","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T08:10:09Z","timestamp":1542010209000},"page":"180-193","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Establishment and characterization of <scp>CRISPR<\/scp>\/Cas9\u2010mediated <i><scp>NF<\/scp>2<\/i><sup><i>\u2212\/\u2212<\/i><\/sup> human mesothelial cell line: Molecular insight into fibroblast growth factor receptor 2 in malignant pleural mesothelioma"],"prefix":"10.1111","volume":"110","author":[{"given":"Md","family":"Wahiduzzaman","sequence":"first","affiliation":[{"name":"Department of Biochemistry Aichi Medical University School of Medicine  Nagakute Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2165-7565","authenticated-orcid":false,"given":"Sivasundaram","family":"Karnan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry Aichi Medical University School of Medicine  Nagakute Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6296-2921","authenticated-orcid":false,"given":"Akinobu","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Biochemistry Aichi Medical University School of Medicine  Nagakute Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Hanamura","sequence":"additional","affiliation":[{"name":"Division of Hematology Department of Internal Medicine Aichi Medical University School of Medicine  Nagakute Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Pathology Aichi Medical University School of Medicine  Nagakute Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Inoko","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Prevention Aichi Cancer Center Research Institute  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Lutfur","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Biochemistry Aichi Medical University School of Medicine  Nagakute Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Hyodo","sequence":"additional","affiliation":[{"name":"Department of Biochemistry Aichi Medical University School of Medicine  Nagakute Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry Aichi Medical University School of Medicine  Nagakute Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Tsuzuki","sequence":"additional","affiliation":[{"name":"Department of Biochemistry Aichi Medical University School of Medicine  Nagakute Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Hosokawa","sequence":"additional","affiliation":[{"name":"Department of Biochemistry Aichi Medical University School of Medicine  Nagakute Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2004.04.001"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0903"},{"key":"e_1_2_8_4_1","first-page":"63","article-title":"Modern management of malignant pleural mesothelioma","volume":"7","author":"Patel SC","year":"2016","journal-title":"Lung Cancer"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/18.4.825"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgt166"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.855"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1008"},{"key":"e_1_2_8_10_1","first-page":"5547","article-title":"p16 alterations and deletion mapping of 9p21\u2010p22 in malignant mesothelioma","volume":"54","author":"Cheng JQ","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.08.014"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.24.10854"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000394"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0000000000000250"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-008-0689-3"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.02.013"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3907"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.6.2384-2394.2005"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206593"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgw084"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2013.143"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1179"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.06.027"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13013"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1971"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3520"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209809"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14109"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-14-0038"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1172"},{"key":"e_1_2_8_31_1","first-page":"75","article-title":"Hippo\/YAP pathway for targeted therapy","volume":"3","author":"Felley\u2010Bosco E","year":"2014","journal-title":"Transl Lung Cancer Res"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2010.06.015"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm_00000132"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2005.01.003"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.643.2.11"},{"key":"e_1_2_8_36_1","first-page":"875","article-title":"Co\u2010expression of keratinocyte growth factor and K\u2010sam is an independent prognostic factor in gastric carcinoma","volume":"21","author":"Toyokawa T","year":"2009","journal-title":"Oncol Rep"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12194"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0050"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3464"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.802"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001451"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11404"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2006.00386.x"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcas.13871","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cas.13871","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cas.13871","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cas.13871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:23:19Z","timestamp":1694737399000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cas.13871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,14]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1111\/cas.13871"],"URL":"https:\/\/doi.org\/10.1111\/cas.13871","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,14]]},"assertion":[{"value":"2018-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}